EXIT TO AMWELL: Amwell Enhances Virtual Care Platform with Acquisition of Conversa Health
As healthcare’s conversation platform, Conversa delivers an easy and meaningful way for care teams and patients to communicate. Conversa has an extensive library of over 330 clinically-intelligent conversation programs that include asthma, chronic obstructive pulmonary disease (COPD), congestive heart failure (CHF), diabetes, hypertension, joint replacement, and many more. Recently Juniper Research stated that “Conversa is the type of company that, through their presence in the market and the kind of product they offer, have the potential to reshape the whole digital health sector. They are an AI company disrupting healthcare in a big way.” Using Conversa’s innovative and scalable Conversational AI technology, healthcare organizations can deliver automated, personalized doctor-patient conversation experiences that lead to more informed and meaningful patient relationships, effective population management and, ultimately, better clinical and financial outcomes.